The key change to take note of is summarized early in the CNA article: “All Integrated Shield Plans that are purchased or renewed from Apr 1 will only cover treatments on an approved cancer drug list.”
This move was made to help control costs of cancer treatment by enabling access to a list of 340 drugs. This list was curated to ensure Singaporeans can continue to receive world class treatments, whilst using drugs that have been proven to be clinically and cost effective.
Overall, as practitioners, we welcome and support this move.
Naturally, it is expected that Singaporeans will be filled with doubt and worry after reading this news. After all, when one buys health insurance; it is with the hope that we can gain access to the best treatment, no matter the costs.
This cancer drug list is currently comprehensive and effective as it stands, and we strongly expect our nation to lobby companies to compromise on the prices; and hence we expect this list and coverage to continue to grow over time.
There is no need to worry that Singapore will be missing out on the best oncological treatments. For the small subset of patients who need pioneering, expensive drugs; there is always the possibility to enrol in various clinical trials with the blessing of the an oncologist.
If you are an agent or a worried client, drop us an email at firstname.lastname@example.org. We will do our best to explain to you the latest changes. Not to worry Singapore, we are well covered